We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Streamlines Orphan Drug Process, Details Fee-Reduction Filings, Appeals
EMA Streamlines Orphan Drug Process, Details Fee-Reduction Filings, Appeals
June 12, 2013
The European Medicines Agency May 8 released a guideline for orphan drug sponsors on how to file applications and request fee reductions under a new streamlined procedure.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor